Clinical Trial Update: Pregabalin Treatment Of Peripheral Neuropathic Pain Associated With Diabetic Peripheral NeP (DPN), Postherpetic Neuralgia (PHN), HIV-related NeP (HIV), and Chemotherapy Induced NeP [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update of pregabalin for peripheral neuropathic pain conditions including diabetic peripheral neuropathic pain and postherpetic neuralgia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Neuropathic Pain
• Diabetic Peripheral Neuropathic Pain
• Hiv-related Neuropathic Pain
• Postherpetic Neuralgia

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Diabetic Peripheral Neuropathic Pain (DPN), Postherpetic Neuralgia (PHN) | Phase 4 | Status: COMPLETED | Results posted: 2009-08-19